Stockwinners Market Radar for February 01, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:22 EDT Kayne Anderson Midstream/Energy Fund reports net assets $640M as of January 31 - As of January 31, the Fund's net assets were $640M and its net asset value per share was $13.09. As of January 31, the Fund's asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 433% and the Fund's asset coverage ratio under the 1940 Act with respect to total leverage was 321%.

18:15 EDT ATEC says 'disappointed' U.S. Army did not select dual-spool T900 for ITEP - The Advanced Turbine Engine Company, a joint venture between Honeywell (HON) and Pratt & Whitney, a division of United Technologies (UTX), was notified by the U.S. Army that it was not selected for the Engineering and Manufacturing Development phase of the Improved Turbine Engine Program. "We were disappointed to learn that the U.S. Army did not select our offering, the dual-spool T900," said Craig Madden, president of ATEC. "We believe that we offered the most advanced, capable and lowest risk engine for ITEP for the Army to improve the overall performance of its Apache and Black Hawk fleets."

18:01 EDT Orthofix acquires Options Medical, terms not disclosed - Orthofix Medical announced that it has acquired the business of Options Medical, a medical device distributor based in Florida. Under the terms of the agreement, employees of Options Medical became employees of Orthofix effective February 1.

17:53 EDT SPDR Gold Shares holdings fall to 817.40MT from 823.87MT - This is the first decline in holdings since January 10th.

17:35 EDT AirMedia gives update on CEO Herman Man Guo's share purchase plan - AirMedia Group announced that its chairman, CEO, and CFO Herman Man Guo had continuously proceeded with his share purchase plan, which was previous announced by the company on March 28, 2018 and updated on September 28, 2018. As of January 30, 2019, Guo had purchased an aggregate of 1.72M American depositary shares, or ADSs, over the period of December 7, 2018 to January 30, 2019 at an average purchase price of approximately 35c per ADS. Due to the restrictions on insider trading starts on January 31, 2019, Mr. Guo will temporarily stop his repurchase from January 31, 2019 until 48 hours after the company files its 2018 Form-20F.

17:28 EDT General Electric awarded $517.38M Army contract for turbine engine program - General Electric has been awarded a $517.38M cost-plus-incentive-fee and firm-fixed-price contract for the engineering and manufacturing development phase of the improved turbine engine program. Two bids were solicited via the internet with two bids received. Work will be performed in Lynn, Massachusetts, with an estimated completion date of August 1, 2024. FY19 research, development, test and evaluation funds in the amount of $130M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.

17:16 EDT CenterPoint Energy to voluntarily delist outstanding VUHI notes from NYSE - CenterPoint Energy, Inc. announced that Vectren Utility Holdings, Inc., a wholly owned subsidiary of CenterPoint Energy, has notified the New York Stock Exchange of its intention to voluntarily delist VUHI's 6.10% Senior Notes due December 1, 2035 from the NYSE. VUHI also intends to terminate the registration of the Notes and the related guarantees, and the reporting obligations of VUHI with respect to the Notes and guarantees, under the Securities Exchange Act of 1934, as amended. VUHI plans to file a Notification of Removal from Listing on Form 25 with the Securities and Exchange Commission on or about February 11, 2019, and the listing of the Notes on the NYSE will terminate 10 days after the Form 25 is filed.

17:13 EDT Black Hills files consolidated rate review proposal in Colorado - Black Hills Corp. announced that its natural gas utility Black Hills Colorado Gas, doing business as Black Hills Energy, filed a rate review proposal with the Colorado Public Utilities Commission to consolidate the rates, tariffs and services of its two legacy gas utilities in Colorado. The rate review also requests $2.5M in new revenue to recover investments in safety, reliability and system integrity for natural gas service to its 187,000 Colorado customers.

16:59 EDT Evolus receives FDA approval for Jeuveau - Evolus announced that the U.S. FDA has approved its lead product, Jeuveau, for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults. Jeuveau is expected to be available throughout the United States at physician offices starting in Spring 2019.

16:45 EDT Whale Rock Capital takes 5.72% passive stake in Coupa Software - Whale Rock Capital disclosed a 5.72% passive stake in Coupa Software. The stake represents over 3.4M shares. The filing with the SEC does not allow for activism.

16:43 EDT Victory Capital reports 5.48% passive stake in Nuance - In a regulatory filing, Victory Capital disclosed a 5.48% passive stake in Nuance Communications, which represents about 15.76M shares. The filing does not allow for activism.

16:40 EDT Victory Capital takes 5.19% passive stake in Helix Energy - Victory Capital disclosed a 5.19% passive stake in AngioDynamics. The stake represents over 2.1M shares. The filing with the SEC does not allow for activism.

16:34 EDT Performance Food Group names George Holm chairman of the board - Performance Food Group Company announced that its President & Chief Executive Officer George L. Holm, was appointed Chairman of PFG's Board of Directors, effective on January 31, 2019. Holm succeeds Douglas M. Steenland, who resigned from his position as Chairman of the Board and as a member of the Board on January 30, 2019. Steenland had been Chairman of the Board since 2010. In connection with Mr. Steenland's resignation, the Board also appointed current director Manuel A. Fernandez to serve as Lead Independent Director of the Board. Holm will continue to serve as PFG's President & CEO, a role he has served in since May 2008. Over that period, PFG's net sales have grown from approximately $10 billion in fiscal 2009 to approximately $17.6 billion in fiscal 2018.

16:29 EDT Alkermes briefly falls, rebounds after announcing CRL for ALKS 5461 - After the market close on February 1, Alkermes (ALKS) announced it received a Complete Response Letter, or CRL, from the FDA regarding its New Drug Application, or NDA, for ALKS 5461 for the adjunctive treatment of major depressive disorder, or MDD. FDA COMPLETE RESPONSE LETTER: The CRL stated that the FDA was unable to approve the ALKS 5461 NDA in its present form, and was requesting additional clinical data to provide substantial evidence of effectiveness of ALKS 5461 for the adjunctive treatment of MDD. Alkermes said it plans to meet with the FDA to discuss the contents of the CRL and potential next steps for ALKS 5461. This interaction with the FDA will inform whether there is a viable path forward for the ALKS 5461 program. The NDA submission for ALKS 5461 was based on results from a clinical efficacy and safety package with data from more than 30 clinical trials and more than 1,500 patients with MDD. ALKS 5461: ALKS 5461 is a proprietary, investigational, once-daily oral medicine that acts as an opioid system modulator and represents a novel mechanism of action for the adjunctive treatment of MDD, in patients with an inadequate response to standard antidepressant therapies. An estimated 16.2M people in the U.S. suffered from MDD in 2016, the majority of whom may not adequately respond to initial antidepressant therapy. CRL EXPECTED BY ALKERMES CEO: On January 8, Alkermes CEO Richard Pops, during a breakout session at the JPMorgan Healthcare Conference, said his company expected the FDA to issue a Complete Response Letter for its depression candidate ALKS 5461. PRICE ACTION: After initially falling 10% in reaction to the news after-hours, shares of Alkermes are little changed, down 0.2% to $33.08.

16:26 EDT Victory Capital takes 6.64% passive stake in Asbury Automotive - Victory Capital disclosed a 6.64% passive stake in Asbury Automotive. The stake represents over 1.3M shares. The filing with the SEC does not allow for activism.

16:19 EDT Victory Capital takes 5.91% passive stake in AutoNation - Victory Capital disclosed a 5.91% passive stake in AutoNation. The stake represents over 5.3M shares. The filing with the SEC does not allow for activism.

16:15 EDT Stage Stores receives noncompliance notice from NYSE - Stage Stores announced that it received notification from the New York Stock Exchange on January 28, 2019 that the company is no longer in compliance with the NYSE continued listing criteria that requires listed companies to maintain an average closing share price of at least $1.00 over a consecutive 30 trading-day period. The NYSE notification does not affect Stage Store's business operations or its Securities and Exchange Commission reporting requirements, nor does it conflict with or cause an event of default under the company's credit facility.

16:13 EDT Victory Capital reports 6.56% passive stake in Alamo Group - In a regulatory filing, Victory Capital disclosed a 6.56% stake in Alamo Group, which represents 770,000 shares. The filing does not allow for activism.

16:09 EDT Kandi Technologies CFO Mei Bing resigns to pursue other opportunities - Kandi Technologies Group announced that Mr. Mei Bing, resigned from the Chief Financial Officer position for his personal reasons, to pursue other opportunities effective January 29, 2019. The board of directors approved his resignation. Mr. Mei's resignation is not the result of any dispute or disagreement with the company. The board has appointed Ms. Zhu Xiaoying as interim Chief Financial Officer, effective January 29, 2019. Additionally, the board has appointed Ms. Wang Yuanyao as Vice President of Finance, effective February 1, 2019.

16:03 EDT Kewaunee Scientific names David S. Rhind chairman of the board - Kewaunee Scientific Corporation announced that David S. Rhind has been appointed chairman of the board of directors of the company. Rhind succeeds William A. Shumaker who served as chairman of the board since 2013 and who resigned effective January 31, 2019. Rhind has served as a director for the company since 2008 and as chairman of the Nominating and Corporate Governance Committee since June 2011.

16:01 EDT NN, Inc CFO Thomas Burwell to step down - NN, Inc announced that Chief Financial Officer Thomas C Burwell will be departing from the company. Mr. Burwell has agreed to remain in his current role and assist with an orderly transition while a search for a replacement is conducted. NN will focus on external candidates to fill the role.

15:57 EDT WildHorse Resource trading resumes

15:57 EDT SendGrid trading resumes

15:55 EDT U.S. Concrete shares up over 4% in late afternoon trading - Shares of U.S. Concrete are trading 4.1% higher to $37.06 in late afternoon trading, after reports that President Trump will address infrastructure in his State of the Union address on Tuesday.

15:44 EDT Evolus trading halted, news pending

15:15 EDT Ekso Bionics jumps after Reuters report highlights Boeing use of exoskeletons - Boeing (BA) is equipping mechanics with exoskeletons to increase their strength and speed and help reduce fatigue on repetitive tasks, according to a Reuters report from Eric Johnson and Tim Hepher. In a photo of employee Rob Gross, who "gets a boost from a gas-powered exoskeleton Boeing is using to boost productivity and safety," an Ekso logo can be seen. Shares of small cap Ekso Bionics (EKSO) have jumped 17c, or 10%, to $1.91 in afternoon trading following the circulation of Reuters' report. Reference Link

14:44 EDT BVF Partners reports 9.99% stake in Vical, holding talks about alternatives - Biotechnology Value Fund Partners disclosed a 9.99% stake in Vical, stating in a regulatory filing that they believe that Vical "remains undervalued and that additional value could be realized through pursuing a variety of strategic alternatives and pathways." To that end, BVF have spoken with members of management from the company "for the purpose of proposing and helping to evaluate such strategic alternatives." BVF intend to continue to engage in discussions with the company's management team and may engage in discussions with the Board of Directors, other stockholders of the company and other interested parties, the filing added.

13:34 EDT Peoples Financial announces common stock repurchase plan - Peoples Financial Services Corp., the bank holding company for Peoples Security Bank and Trust Company, announced that its board has authorized a stock repurchase plan providing for the purchase of up to 225,000 shares of its outstanding common stock. As of the date of this release, Peoples has approximately 7.4M shares of common stock outstanding.

13:04 EDT Bandera Partners issues statement on 'inadvertent error' at Luby's election - Bandera Partners, a significant stockholder of Luby's, issued the following statement: "At the Luby's Annual Meeting of Stockholders held on January 25, 2019, an agent of Bandera Partners submitted a Master Ballot to the Inspector of Elections that contained an inadvertent error that was not discovered by Bandera or its advisors. After the results of the election were certified on January 30, 2019, Bandera Partners became aware of the error that led to its proxies not being voted in favor of five of Luby's nominees, as intended and planned. To the extent Luby's lawyers were aware of the error, they chose not to inform us of our mistake. Once Bandera became aware of the error, we offered to work with Luby's after certification to have our proxies voted in favor of those management nominees for whom we always intended to vote. Bandera Partners' offer to try to fix this mistake has not been accepted by the Company. We are immensely grateful to our fellow Luby's stockholders who supported us with their proxies, and we want them to understand what happened, and hear this clarification. Bandera apologizes to Luby's five nominees, and especially Joe McKinney, who should have surpassed the 50% threshold for election with our support."

13:03 EDT Baker Hughes reports U.S. rig count down 14 to 1,045 rigs - Baker Hughes reports that the U.S. rig count is down 14 rigs from last week to 1,045 rigs, with oil rigs down 15 to 847 and gas rigs up 1 to 198. The U.S. Rig Count is up 99 rigs from last year's count of 946, with oil rigs up 82 and gas rigs up 17. The U.S. Offshore Rig Count is down 1 rig to 19 and up 3 rigs year-over-year. The Canada Rig Count is up 11 rigs from last week to 243, with oil rigs up 13 to 159 and gas rigs down 2 to 84. The Canada Rig Count is down 99 rigs from last year's count of 342, with oil rigs down 75 and gas rigs down 24.

12:19 EDT Interactive Brokers reports January DARTs down 6% y/y - Interactive Brokers Group reported its Electronic Brokerage monthly performance metrics for January. Brokerage highlights for the month included: 851,000 Daily Average Revenue Trades, 6% lower than prior year and 11% lower than prior month. Ending client equity of $139.2B, 4% higher than prior year and 8% higher than prior month. Ending client margin loan balances of $23.8B, 21% lower than prior year and 12% lower than prior month. Ending client credit balances of $51B, including $1.8B in insured bank deposit sweeps1, 5% higher than prior year and 3% higher than prior month. 607,000 client accounts, 22% higher than prior year and 1% higher than prior month. 320 annualized average cleared DARTs per client account. Average commission per cleared client order of $3.57 including exchange, clearing and regulatory fees.

12:04 EDT TD Bank announces organizational changes to U.S. Consumer Products unit - TD Bank announced organizational changes to its U.S. Consumer Product team as it unites U.S. Bankcard, Retail Card Services, U.S. Partnerships and Personal Lending into one portfolio under Matt Boss, now Head of U.S. Credit Cards and Unsecured Lending. This decision reflects the bank's momentum in the consumer lending space as it continues to grow its portfolio of customized offerings. With this new alignment, Mike Kinane, who previously headed up TD's home equity lending business as Senior Vice President, Head of Home Equity and Personal Lending, has been appointed to Head of U.S. Bankcard. Kinane will oversee the bank's TD-branded credit card portfolio, a business that started at TD Bank under his leadership in 2012. Kinane brings deep expertise in the consumer credit space, having held a variety of leadership roles across consumer lending business during his tenure at TD.

12:00 EDT Celestica falls -16.3% - Celestica is down -16.3%, or -$1.62 to $8.31.

12:00 EDT Yum China rises 10.2% - Yum China is up 10.2%, or $3.70 to $40.15.

12:00 EDT Bloom Energy rises 13.9% - Bloom Energy is up 13.9%, or $1.31 to $10.76.

11:43 EDT Chevron CEO says increase in share repurchases show 'confidence'

11:25 EDT Nissan reports January U.S. sales down 18.5% to 100,741 units - Nissan Group announced total U.S. sales for January of 100,741 units, a decrease of 18.5% compared to the prior year. Nissan Division sales declined 19.9% to 90,439 units while Infiniti division sales decreased 3.1% to 10,302 units.

11:19 EDT Chevron expecting to sell Danish assets during first half of FY19 - Chevron will sell assets in UK, Azerbaijan, and Brazil.

11:01 EDT Toyota reports January U.S. sales down 6.6% to 156,021 vehicles - Toyota Motor North America reported January 2019 sales of 156,021 vehicles, a decrease of 6.6% from January 2018 on a volume basis. With the same number of selling days year over year, sales were down 6.6% on a daily selling rate basis.

10:41 EDT TORM PLC (Class A Stock) trading resumes

10:18 EDT Dr. Reddy's names Marc Kikuchi to lead generics business in North America - Dr. Reddy's Laboratories announced the appointment of Marc Kikuchi as CEO, North America Generics. As part of the Dr. Reddy's senior leadership team, he will be responsible for the company's North America Generics business and will be based in Princeton office, U.S.

10:00 EDT Curo Group rises 8.1% - Curo Group is up 8.1%, or $1.01 to $13.51.

10:00 EDT Enova International rises 9.5% - Enova International is up 9.5%, or $2.18 to $25.23.

09:51 EDT Twilio completes SendGrid acquisition, transaction valued at approximately $3B - Twilio announced the successful completion of its previously announced acquisition of email API platform SendGrid.This follows approval by the stockholders of both companies at separate meetings on Jan. 30. This transaction is valued at approximately $3B. Based on the closing price of Twilio Class A common stock on Jan. 31 and the exchange ratio of 0.485 shares of Twilio Class A common stock per share of SendGrid common stock, SendGrid stockholders received approximately $53.99 of aggregate value per share of SendGrid common stock. As a result of the acquisition, shares of common stock of SendGrid ceased trading prior to the open of the market on Feb. 1, 2019 and will no longer be listed on the New York Stock Exchange. "Effective customer engagement is a strategic imperative for every company. With SendGrid now a part of Twilio, our goal is to provide a complete platform for every form of customer engagement," said Jeff Lawson, Twilio co-founder and CEO. "Through our mutual developer-first approach, we empower the builders of the world to create magical customer experiences unique to every interaction." SendGrid will operate as a wholly owned subsidiary of Twilio and will continue to be led by SendGrid CEO Sameer Dholakia, reporting to Lawson. "The acquisition of SendGrid signals that Twilio is redefining its position in the market, enhancing its customer engagement capabilities with a comprehensive omnichannel offering," said Raul Castanon-Martinez, senior analyst, 451 Research. "The deal should also help cement its position in the enterprise. This could give Twilio added momentum for expanding its customer base and support continued revenue growth."

09:47 EDT Vedanta falls -18.2% - Vedanta is down -18.2%, or -$2.03 to $9.14.

09:47 EDT Booz Allen rises 7.8% - Booz Allen is up 7.8%, or $3.81 to $52.94.

09:47 EDT Deckers Brands rises 14.4% - Deckers Brands is up 14.4%, or $18.45 to $146.90.

09:35 EDT Continental Materials spikes 27% after announcing sale of Transit Mix Concrete - Continental Materials announces the sale of substantially all the assets of Transit Mix Concrete, a leading supplier of building materials in Colorado to Aggregate Industries - WCR, a subsidiary of LafargeHolcim, for approximately $27M. The transaction includes the ready-mix plant operations in Colorado Springs and Pueblo, Colorado and the Daniels sand pit in Colorado Springs, Colorado. "We are pleased to find a supportive new partner for Transit Mix, who will invest and grow the ready-mix and sand operations in Southern Colorado and retain over 180 skilled and experienced employees. Since Continental Materials acquired Transit Mix in 1955, it has overseen steady growth through long term investment, from a single operation to the current business with $60m revenue and several locations along the Southern Front Range," said Jim Gidwitz, Chairman of Continental Materials. "With the proceeds from the sale Continental Materials will look to invest in US based manufacturing businesses with a long term outlook." Continental Materials is retaining its building supply and aggregates businesses in Colorado, which will be rebranded as Castle Rebar and Supply and Castle Concrete Aggregates, respectively. Shares of Continental Materials are up 26.8% or $4.00 per share to $18.90 per share.

09:21 EDT Tyler Technologies to acquire MicroPact from Arlington Capital for $185M in cash - Tyler Technologies announced it has signed a definitive agreement to acquire MicroPact for approximately $185M in cash. The transaction is targeted to close on March 15, 2019, pending federal regulatory approvals. Founded in 1997 by CEO Kristoffer Collo, MicroPact was formerly known as MicroPact Engineering and since 2012 has operated as MicroPact through several affiliated entities. The company is based in Herndon, VA, employs 469 people, and has annual revenues of more than $70M.

09:08 EDT Buenaventura resumes operations at Orcopampa mine - Buenaventura announced that it has resumed operations at its Orcopampa mine. As was announced on December 12, 2018, the company decided to temporarily suspend production at the Orcopampa mine, beginning on December 17, 2018 through January 31, 2019. This is consistent with the Buenaventura's strategy of prioritizing Orcopampa's De-bottlenecking Program over ore extraction. In accordance with Buenaventura's communicated plan, the existing infrastructure was successfully optimized by improving the mine ventilation system and reinforcing the galleries to ensure the safety of Orcopampa's on site team. All activities at both the mine and the plant will resume with no delays.

09:04 EDT ToughBuilt announces distribution agreement with Toolbank - ToughBuilt announced it has entered into a distribution agreement with Toolbank. Toolbank specializes in the distribution of hand tools, power tools, consumables, accessories, fixings and fasteners to the retail and merchant trades throughout the United Kingdom and Ireland, as well as across Europe. As a specialist distributor of many of the most well known worldwide tool and accessory brands/manufacturers, Toolbank currently stocks over 30,000 products.

08:56 EDT Honeywell says expects to achieve 'upper end' of FY19 sales guidance

08:53 EDT Research Frontiers, Gauzy announce second production facility in Germany - Research Frontiers and Gauzy announced Gauzy's second production facility in Stuttgart, Germany to produce SPD-Smart light control film for the entire SPD-SmartGlass industry, including automotive and architectural applications. Gauzy expects the new facility to be in production within the next six months. The company will host a special invitation-only event for industry professionals, key customers, and media later this year to launch the new production site. It can coat SPD light-control film as wide as 1.8 meters. This follows the inauguration of Gauzy's previously announced SPD film production line in Tel Aviv this past October. That facility has the capacity to produce up to 364 thousand square meters of film per year per shift.

08:45 EDT Sirius XM completes acquisition of Pandora - Sirius XM Holdings (SIRI) announced that it has completed its acquisition of Pandora Media (P). With the transaction complete, SiriusXM is the world's largest audio entertainment company with strong, long-term growth opportunities. As previously announced, the outstanding shares in Pandora not already owned by SiriusXM will be exchanged for a fixed ratio of 1.44 newly issued SiriusXM shares. Shares of Pandora's common stock are no longer trading on the New York Stock Exchange.

08:43 EDT WildHorse Resource trading halted, news dissemination

08:36 EDT Honeywell says does not expect 'any material impact' on FY results from tariffs - Says not planning for recession in FY19. Comments from Q4 earnings conference call.

08:34 EDT Cesca Therapeutics' ThermoGenesis PXP System selected by Orthohealing Center - Cesca Therapeutics-owned private corporation ThermoGenesis has entered into a Supply Agreement with Orthohealing Center Management that will allow the OCM network of physicians to utilize the ThermoGenesis PXP system to prepare a precise cell concentrate from autologous bone marrow in their office laboratories in order to provide the benefits of their Orthohealing Method to their patients.

08:33 EDT Chevron sees 2019 production up 4%-7% excluding impact of asset sales

08:32 EDT Two Harbors appoints Mary Riskey as CFO - Two Harbors Investment confirmed the appointment of Mary Riskey as VP, CFO effective February 1, 2019. The appointment of Riskey as CFO became effective following the previously announced resignation of Brad Farrell as of January 31, 2019. Riskey joined Two Harbors in 2011 and has most recently served in the role of VP, Acting CFO and Treasurer, since October 2018. Additionally, the company announced that its Board of Directors has appointed Sheila Lichty to serve as VP and Treasurer, effective February 1, 2019. Lichty will work closely with and report directly to Mary Riskey. Lichty joined Two Harbors in 2013 and has most recently served as Assistant Treasurer of the company.

08:21 EDT Taronis Technologies announces official name change from MagneGas - Taronis Technologies formally announced its corporate rebrand and name change. The company is now known as Taronis Technologies.

08:18 EDT Landmark Infrastructure amends omnibus agreement to extend reimbursement - Landmark Infrastructure announced that it amended its omnibus agreement with Landmark Infrastructure Partners GP and Landmark Dividend. The amendment to the Omnibus Agreement, among other things, extends the period of time for which the sponsor will reimburse a portion of the partnership's general and administrative expenses. The cap for general and administrative reimbursement has been revised to 3% of the partnership's consolidated revenue during the current calendar quarter and will last until the earlier of the date on which the partnership's consolidated revenue for the immediately preceding four consecutive fiscal quarters exceeds $120M and November 19, 2021.

08:16 EDT Greif receives antitrust clearance for Caraustar acquisition - Greif announced that it has received notice that the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act regarding Greif's pending acquisition of Caraustar Industries. As this was the last regulatory approval required to complete the pending acquisition, Greif and Caraustar Industries expect the acquisition to close on February 11, subject to customary closing conditions.

08:15 EDT Roche says CHMP recommends EU approval of Tecentriq in combination with Avastin - Roche announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of Tecentriq, in combination with Avastin, paclitaxel and carboplatin, for the first-line treatment of adults with metastatic non-squamous non-small cell lung cancer. In people with EGFR mutant or ALK-positive NSCLC, Tecentriq, in combination with Avastin, paclitaxel and carboplatin, is indicated only after failure of appropriate targeted therapies. Based on the positive CHMP recommendation, a final decision regarding the approval of this Tecentriq-based combination is expected from the European Commission in the near future. The CHMP recommendation is based on results from the Phase III IMpower150 study, which showed that Tecentriq in combination with Avastin, paclitaxel and carboplatin helped people live significantly longer, compared with Avastin and chemotherapy in the intention-to-treat population. The safety profile of the Tecentriq combination was consistent with that observed in previous studies.

08:14 EDT Vectren trading halted, news dissemination

08:07 EDT Iridium COO Scott Smith to retire, Suzi McBride to succeed - Iridium Communications announced that COO Scott Smith has decided to retire effective March 15th. Smith will continue to work with Iridium in a consulting role as the handoff to his successor is completed, with the company wishing him well in his greatly earned retirement. In conjunction with this announcement, the company is welcoming back to Iridium new COO Suzi McBride. McBride will assume this position effective as of February 11. Prior to rejoining Iridium, McBride spent the past two-and-a-half years at OneWeb, where she served as COO and Senior Vice President.

08:06 EDT Berry Global reaffirms FY19 adjusted free cash flow view $670M - The company said, "We are reaffirming our fiscal year 2019 projected cash flow from operations of $1.04B and adjusted free cash flow of $670M. Our estimate assumes constant currency rates from the end of fiscal 2018 and a normal inflationary environment on our costs. Additionally, our fiscal 2019 capital spending and cash interest costs are forecasted to be $350M and $270M, respectively. Within our adjusted free cash flow guidance, we are also assuming cash taxes to be $165M in fiscal 2019, including the $16M payment made in the first fiscal quarter under the Company's tax receivable agreement, along with working capital and other cash uses of $45M."

08:04 EDT Alamo Group to build new $15M vacuum truck manufacturing facility in Wisconsin - Alamo Group announced that it has approved plans to build a new $15M facility for its Super Products vacuum trucks operation. The facility will be located in the Village of Mukwonago, Wisconsin and will allow the company to consolidate and expand current production which operates out of several facilities in the greater Milwaukee area. The plant is anticipated to commence operations in the first quarter of 2020. The facility will be approximately 70% larger than the combined capacity of the existing operations and will allow Super Products to consolidate its manufacturing and customer support operations into a single, highly efficient location. It will also enable Super Products to bring in house high value operations that are currently outsourced due to capacity limitations. The site also offers the potential to expand operations to meet future needs. Since being acquired by Alamo Group in 2014, Super Products has grown steadily, in part by expanding its network of vacuum truck rental stores to serve a wider geographic market. In 2018, Super Products opened two new rental locations in Savannah, Georgia and Corpus Christi, Texas and now operates eight rental locations in seven states. The additional capacity provided by the larger facility will allow Super Products to continue its growth in the coming years.

08:02 EDT Steel Dynamics to acquire 75% equity interest in United Steel Supply for $134M - Steel Dynamics announced that it has entered into a definitive agreement to acquire a majority of the equity interest of United Steel Supply. United Steel Supply is headquartered in Austin, Texas and is a leading distributor of painted Galvalume flat roll steel used for roofing and siding applications. Steel Dynamics has agreed to purchase 75% of the equity interests of United Steel Supply for $134M, comprised of cash consideration of $92M and the assumption of $42M in apportioned debt. The purchase price assumes total net working capital of $59M, which is subject to customary post-closing adjustments. Additionally, Steel Dynamics has an option to purchase the remaining 25% equity interest of United Steel Supply in the future. This transaction is valued on a total enterprise value based on five times United Steel Supply's 2018 adjusted EBITDA. The existing USS owners will also have an opportunity to receive an additional earn-out over the five-year period after closing by achieving certain operational and financial metrics expected to benefit both United Steel Supply and Steel Dynamics. This transaction is subject to customary closing conditions and receipt of regulatory approvals.

07:42 EDT Spirit AeroSystems finalizes Definitive Documentation on Boeing agreement - "As we begin 2019, our focus is on the efficient execution of production rate increases, margin expansion, continued growth in defense and fabrication, closure and integration of Asco, and continued commitment to total shareholder return," said Tom Gentile, President and CEO for Spirit AeroSystems. "Earlier this week, we finalized the Definitive Documentation on the Boeing agreement we announced in December. We are very pleased to conclude this long-term, broad-reaching agreement with our largest customer, and we look forward to working with them to execute across all programs." "In the last three months, we have also continued to work on closing the Asco deal. We have made substantial progress in identifying the issues the European Commission raised concerning the Belairbus structure," said Gentile. "This week we refiled our Form CO, which is the formal notification required for merger review and clearance by the European Commission. We hope to receive clearance during the first quarter, and our goal is to close the deal in the first half of the year."

07:37 EDT Natera announces partnership with One Lambda - Natera (NTRA) announced a partnership with Thermo Fisher Scientific's (TMO) One Lambda brand to co-distribute Natera's kidney transplant rejection test in the United States in collaboration with the company's direct sales team.

07:23 EDT Honeywell says expects 'strong start' to 2019 - Says: Expects strong sales and free cash flow growth with continued margin expansion... Strong balance sheet; continuing smart and disciplined capital deployment strategy... Balanced end-market dynamics, multiple self-help levers to drive outperformance. Comments from slides presentation for Q4 earnings conference call.

07:13 EDT Honeywell sees FY19 segment margin 20.7%-21%, up 110-140 bps - For FY19 sees: Long-cycle growth supported by strong backlog; cautious assumptions on short-cycle growth given uncertain macro... Balanced outlook with multiple cost levers in the event of a slowdown; plan assumes no recession... Adjusted free cash flow conversion remains near 100%... Minimal impact from tariffs expected in 2019 after mitigation actions... Planning at least (1%) share count reduction in 2019... Net below the line impact ~($80M). Comments from slides presentation for Q4 earnings conference call.

07:02 EDT Navidea announces extension of NYSE American listing - Navidea Biopharmaceuticals announced the receipt of a notice from the NYSE American on January 28, 2019 that the NYSE American has granted the Company an extension until March 31, 2019 to regain compliance with Section 1003(f)(v) of the NYSE American's continued listing standards. Navidea previously disclosed that it received a notification from the NYSE American stating that Navidea was not in compliance with certain provisions of the NYSE American continued listing standards, including Section 1003(f)(v), which relates to the selling price per share of the Company's securities. The NYSE American staff initially granted Navidea a plan period through February 14, 2019 to regain compliance with Section 1003(f)(v) by effecting a reverse stock split or otherwise demonstrating sustained price improvement. In August 2018, Navidea's stockholders voted to approve a potential amendment to the Company's amended and restated certificate of incorporation to effect a reverse split of the Company's common stock, as determined by the Board of Directors at its discretion, of a ratio of not less than one-for-five and not more than one-for-twenty. Navidea's Common Stock will continue to be listed on the NYSE American while it attempts to regain compliance with the listing standards noted, subject to Navidea's compliance with other continued listing requirements.

06:56 EDT Merck says FY19 adjusted EPS guidance includes about 1% positive impact from FX - Says FY19 revenue guidance includes approximately 1% negative impact from FX.

06:51 EDT Teva receives positive CHMP opinion for AJOVY - Teva announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended granting a marketing authorization for AJOVY 225 mg solution for injection in pre-filled syringe for the prophylaxis of migraine in adults who have at least four migraine days per month. If approved by the European Commission, AJOVY, a humanized monoclonal antibody that binds to the calcitonin gene-related peptide ligand and blocks its binding to the receptor, will be the first and only anti-CGRP treatment in the European Union with both quarterly and monthly dosing options.

06:49 EDT Merck sees FY19 adjusted tax rate 18.5%-19.5% - Sees FY19 adjusted operating expenses higher than 2018 by a low- to mid-single digit rate.

06:47 EDT Invitation Homes raises dividend to 13c per share from 11c per share - Invitation Homes announced that it has declared a quarterly cash dividend of $0.13 per share payable on shares of its common stock, representing an 18.2% increase over the prior quarterly dividend of 11c per share. The dividend will be paid on or before February 28, to stockholders of record of the company's common stock as of the close of business on February 13.

06:43 EDT Macau reports January casino revenue down 5.0% to 24.94B patacas - Macau's gaming bureau reported January gross revenue from games of fortune in the region fell 5.0% year-over-year to 24.94B patacas. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Resorts (MLCO).

06:42 EDT Deutsche Bank cuts 2019 adjusted cost target to EUR21.8B - Given the progress in 2018, management has lowered its 2019 adjusted cost target to 21.8 billion euros, versus 22 billion euros previously. Management reaffirmed its target to reduce the internal workforce to well below 90,000 by the end of 2019. Additionally, Deutsche Bank reaffirmed its commitment to its plans to achieve a post-tax Return on Tangible Equity target of above 4% in 2019.

06:32 EDT Tilly's declares one-time, special cash dividend of $1.00 per share - Tilly's announced that its Board of Directors has declared a special cash dividend of $1.00 per share, or approximately $29.5M in the aggregate, on the company's outstanding Class A and Class B common stock. This one-time, special dividend is payable on February 27 to stockholders of record at the close of business on February 15.

06:21 EDT Roadrunner sees 2018 adjusted EBITDA $15M-$20M

06:14 EDT China Yuchai subsidiary increases ownership in YC Europe to 75% for EUR225,000 - China Yuchai, through its main operating subsidiary, Guangxi Yuchai Machinery, or GYMCL, announced that GYMCL has increased its equity ownership in its subsidiary YC Europe to 75.0% from 67.5%. GYMCL has purchased the 225,000 ordinary shares of YC Europe owned by Heinz Norbert Schuchert, or HNS, representing a 7.5% equity ownership, for a total consideration of EUR225,000 comprising EUR15,000 paid by GYMCL to HNS and EUR210,000 paid by GYMCL to YC Europe being payment of HNS' outstanding contribution to the registered capital of YC Europe. The said consideration is funded by GYMCL's internal funding. YC Europe was incorporated in April 2015 to market off-road engines in Europe.

06:11 EDT Gravity announces Ragnarok M: Eternal Love collaboration - Gravity announced Ragnarok M: Eternal Love has been updated through collaborative events with Neon Genesis Evangelion. Ragnarok M: Eternal Love is in collaboration with "Neon Genesis Evangelion" from January 31 to February 28. This collaboration is updated for Taiwan, Hong Kong, Macau, Korea and Southeast version. During the event, the game offers Evangelion's characters customs and other items. Based on Ragnarok M: Eternal Love's performance, the company predicts a tentative Q4 unaudited consolidated revenue as KRW111B.

06:08 EDT Cigna sees FY19 medical customer growth of 300,000-400,000

06:05 EDT Cigna CEO says 'positioned to deliver outstanding growth' in 2019 - "Cigna completed an exceptionally strong 2018, with revenue, customer, and earnings growth, driven by continued innovation across the business," said David Cordani, President and CEO. "We enter 2019 further strengthened by our combination with Express Scripts and positioned to deliver outstanding growth fueled by accelerated innovation that will improve whole person health and affordability for customers and clients."

05:53 EDT Aphria introduces first cannabis strains produced in Europe - Aphria has completed its first transfer of plant cuttings from four of the company's cannabis strains to Denmark-based Schroll Medical, as part of the company's previously announced Strategic Partnership with Schroll. The shipment was completed under permits issued by the relevant health authorities, including an export permit from Health Canada, an import permit from the Danish Medicines Agency and a phytosanitary certificate from the Canadian Food Inspection Agency.

05:47 EDT Anadarko announces LNG sale, purchase agreement with CNOOC - Anadarko Petroleum (APC) announced Mozambique LNG1 Company Pte. Ltd., the jointly owned sales entity of the Mozambique Area 1 co-venturers, has signed a Sale and Purchase Agreement with CNOOC (CEO). The SPA is for 1.5 million tonnes per annum for a term of 13 years.

05:28 EDT Sempra Energy receives FEIS from FERC for Port Arthur LNG project - Sempra Energy announced it received the Final Environmental Impact Statement, or FEIS, from the Federal Energy Regulatory Commission, or FERC, to construct the Port Arthur LNG natural gas liquefaction-export project in Jefferson County, Texas, as well as the Texas and Louisiana connector pipeline projects that will deliver natural gas to the new export facility. The proposed Port Arthur LNG project is expected to include two natural gas liquefaction trains capable of processing approximately 11 million tonnes per annum, or Mtpa, liquefied natural gas, or LNG, up to three LNG storage tanks and associated facilities and new natural gas transmission pipelines in Texas and Louisiana. The FEIS is the final step in the environmental review process before FERC can proceed to issue an order approving the project.

05:14 EDT Opko Health provides update on development of OPK-88004 - OPKO Health announced an update on the ongoing development plans of OPK-88004, a selective androgen receptor modulator, or SARM. OPK-88004 has the ability to serve as an antagonist to androgen receptors in the prostate, resulting in decreased prostate specific antigen, or PSA, levels, and as an agonist resulting in increased anabolic effects, such as increased lean body mass and physical function and decreased fat mass. Promising clinical data from prior studies suggest that OPK-88004 can be used for the treatment of a number of symptoms such as frailty, physical function and quality of life parameters for various indications. OPKO is currently conducting a Phase 2 clinical trial that evaluates the effect of 15mg and 25mg doses of OPK-88004 on prostate volume in patients with Benign Prostatic Hyperplasia. In reviewing the blinded data, it has been noticed that to measure one of the study's primary endpoints, the trans-rectal ultrasound method proved to be too imprecise to reliably determine the drug effect. Also, although most of the laboratory changes were consistent with this class of drugs, increases in liver enzymes were observed in several men at these higher doses. The increases were transient in patients that completed the trial and returned to normal once the drug was withdrawn. Importantly, no increases in liver enzymes were observed in a previous large Phase 2 study of 420 men taking lower doses of OPK-88004. OPKO plans to suspend the current trial but continue to analyze data relating to the other primary endpoint, the effect of OPK-88004 on serum PSA levels, and the secondary endpoints, changes in lean body mass, or LBM, and fat mass. The results of this data analysis are expected in Q2 2019. OPKO is planning additional exploratory Phase 2 clinical studies to assess the feasibility of OPK-88004 in other indications. One of the trials is designed to study the safety and efficacy of OPK-88004 in prostate cancer patients treated with Androgen Deprivation Therapy, or ADT. ADT results in the reduction of testosterone to castration levels in men with prostate cancer. However, ADT is associated with side effects such as decreased LBM, physical function, bone quality and increases in body fat, frailty and hot flashes. The diminished quality of life results in approximately one-third of men treated with ADT stopping treatment within six months of initiation. OPKO's trial data in aging men indicate that OPK-88004 increases LBM, decreases fat and increases physical function. Because OPK-88004 decreases PSA levels due to its antagonistic effects on the prostate, it may be well-suited to treat men on ADT therapy. The contemplated Phase 2 study is designed to show that OPK-88004 improves ADT-associated symptoms and quality of life of prostate cancer patients. Approximately one million men are receiving ADT therapy in the U.S. Because of OPK-88004's significant increase of muscle mass, or LBM, and strength, and because of OPKO's strong interest in the therapy of chronic kidney disease, or CKD, patients, another Phase 2 trial is planned to treat kidney dialysis patients who have low testosterone levels and commonly suffer from muscle weakness and general frailty. Approximately 500,000 CKD patients are on dialysis therapy in the U.S.